alexa Leukaemia News|OMICS International|Journal Of Leukemia

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Leukaemia News

Leukaemia news includes in general, include two kinds of lymphoma study: clinical or translational study and rudimentary study. Leukaemia also includes clinical/translational study focuses on revising the disease in a characterised and usually immediately patient-applicable way, such as testing a new pharmaceutical in patients. The plasmacytoid dendritic cells leukemia is a rare hematolymphoid neoplasm with a very poor prognosis, where skin involvement is common. It is a malignant proliferation developed at the expense of hematopoietic cells of the white blood cells, proximate to normal plasmacytoid dendritic cells. The phenotype of tumor cells initially described was CD4 + CD56 +, without T marker expression. CD56- forms have also been reported, even fewer without skin involvement. More specific markers are expressed by tumor cells: CD123, BDCA2, BDCA4. We report an unusual presentation of this entity, but without skin lesions. The diagnosis of plasmacytoid dendritic cells leukemia was made on the cytological and immunophenotypic data given. Plasmocytoid Dendritic Cells Leukemia: A Rare Presentation (Tlamáìani Imane, Ghita Yahyaoui, Moncef Amrani Hassani, Salma Benjelloun, Benseddik Najoua, Lhoussine Balouch and Bamou Youssef) Leukaemia news includes in general, include two kinds of lymphoma study: clinical or translational study and rudimentary study. Leukaemia also includes clinical/translational study focuses on revising the disease in a characterised and usually immediately patient-applicable way, such as testing a new pharmaceutical in patients. The plasmacytoid dendritic cells leukemia is a rare hematolymphoid neoplasm with a very poor prognosis, where skin involvement is common. It is a malignant proliferation developed at the expense of hematopoietic cells of the white blood cells, proximate to normal plasmacytoid dendritic cells. The phenotype of tumor cells initially described was CD4 + CD56 +, without T marker expression. CD56- forms have also been reported, even fewer without skin involvement. More specific markers are expressed by tumor cells: CD123, BDCA2, BDCA4. We report an unusual presentation of this entity, but without skin lesions. The diagnosis of plasmacytoid dendritic cells leukemia was made on the cytological and immunophenotypic data given. Plasmocytoid Dendritic Cells Leukemia: A Rare Presentation (Tlamáìani Imane, Ghita Yahyaoui, Moncef Amrani Hassani, Salma Benjelloun, Benseddik Najoua, Lhoussine Balouch and Bamou Youssef)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top